Willis Towers Watson (WTW) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

30.10.25 14:30 Uhr

Werte in diesem Artikel
Aktien

274,00 EUR 0,00 EUR 0,00%

Indizes

6.642,2 PKT 24,8 PKT 0,38%

Willis Towers Watson (WTW) reported $2.29 billion in revenue for the quarter ended September 2025, representing no change year over year. EPS of $3.07 for the same period compares to $2.93 a year ago.The reported revenue represents a surprise of +0.53% over the Zacks Consensus Estimate of $2.28 billion. With the consensus EPS estimate being $3.00, the EPS surprise was +2.33%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Willis Towers Watson performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Health, Wealth and Career: $1.26 billion compared to the $1.25 billion average estimate based on six analysts. The reported number represents a change of -5.1% year over year.Revenue- Reimbursable expenses and other: $14 million compared to the $29.01 million average estimate based on six analysts. The reported number represents a change of -6.7% year over year.Revenue- Segment Revenue: $2.27 billion versus the six-analyst average estimate of $2.24 billion. The reported number represents a year-over-year change of 0%.Revenue- Risk and Broking: $1.01 billion versus the six-analyst average estimate of $991.67 million. The reported number represents a year-over-year change of +7.1%.Segment Operating Income- Risk and Broking: $189 million versus the six-analyst average estimate of $190.41 million.Segment Operating Income- Health, Wealth and Career: $361 million versus the six-analyst average estimate of $337.54 million.View all Key Company Metrics for Willis Towers Watson here>>>Shares of Willis Towers Watson have returned -7.7% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Willis Towers Watson Public Limited Company (WTW): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf Willis Towers Watson

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Willis Towers Watson

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Willis Towers Watson PLC

Wer­bung

Analysen zu Willis Towers Watson PLC

DatumRatingAnalyst
08.02.2019Willis Towers Watson HoldDeutsche Bank AG
05.02.2018Willis Towers Watson BuyStifel, Nicolaus & Co., Inc.
30.06.2017Willis Towers Watson OverweightBarclays Capital
20.10.2016Willis Towers Watson SellDeutsche Bank AG
31.03.2016Willis Towers Watson BuyMKM Partners
DatumRatingAnalyst
05.02.2018Willis Towers Watson BuyStifel, Nicolaus & Co., Inc.
30.06.2017Willis Towers Watson OverweightBarclays Capital
31.03.2016Willis Towers Watson BuyMKM Partners
DatumRatingAnalyst
08.02.2019Willis Towers Watson HoldDeutsche Bank AG
28.03.2016Willis Towers Watson HoldDeutsche Bank AG
DatumRatingAnalyst
20.10.2016Willis Towers Watson SellDeutsche Bank AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Willis Towers Watson PLC nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen